TSHA
Taysha Gene Therapies, Inc.
NASDAQHealthcareBiotechnologyUS
USD5.67
+0.09 (+1.61%)
Rating:C
Company Profile
CEO
Sean Nolan
IPO Date
2020-09-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$5.62
Prev. Close
$5.58
Day Low
$5.59
Day High
$5.79
52W Low
$2.34
52W High
$7.30
Market Cap
$1.42B
Volume
1.78M